Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR/Cas9 Genetic Modification of CYP3A5 *3 in HuH-7 Human Hepatocyte Cell Line Leads to Cell Lines with Increased Midazolam and Tacrolimus Metabolism

22 May 2017

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Pharmacogenetics and Drug Metabolism
Share to Renal Transplantation Outcomes and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28533324
DOI: 10.1124/dmd.117.076307

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR/Cas9 Genetic Modification of CYP3A5 *3 in HuH-7 Human Hepatocyte Cell Line Leads to Cell Lines with Increased Midazolam and Tacrolimus MetabolismPMID 28533324Read ↗

Knocking-down of CYP2C9 expression in Huh-7 and HepG2 cells using CRISPR/Cas9 methodSemantic proximity Read ↗

CYP3A4 and CYP3A5 Expression is Regulated by CYP3A4*1G in CRISPR/Cas9-Edited HepG2 Cells.Semantic proximity Read ↗

CRISPR knockout rat cytochrome P450 3A1/2 model for advancing drug metabolism and pharmacokinetics research.Semantic proximity Read ↗

Human induced pluripotent stem cell line with cytochrome P450 enzyme polymorphism (CYP2C19*2/CYP3A5*3C) generated from lymphoblastoid cells.Semantic proximity Read ↗

Generation of cytochrome P450 polymorphic human induced pluripotent stem cell lines with defective CYP activities.Semantic proximity Read ↗

Expression of drug metabolizing enzymes in hepatocyte-like cells derived from human embryonic stem cellsSemantic proximity Read ↗

Generation of cytochrome P450 enzyme-polymorphic human induced pluripotent stem cell lines with CYP2D6*10/CYP3A5*3C and CYP2D6*10/CYP2C19*2.Semantic proximity Read ↗

MicroRNA hsa-miR-25-3p suppresses the expression and drug induction of CYP2B6 in human hepatocytesSemantic proximity Read ↗

Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cellsSemantic proximity Read ↗

Refining Hepatocyte Models to Capture the Impact of CYP2D6*10 Utilizing a PITCh System.Semantic proximity Read ↗

Phenotypical and functional characterization of a HepG2 cell clone stably overexpressing cytochrome P450 (CYP) 2C9.Semantic proximity Read ↗

A comparison of hepato-cellular in vitro platforms to study CYP3A4 inductionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.